News Image

Which stocks are moving before the opening bell on Wednesday?

By Mill Chart

Last update: Sep 28, 2022

Let's have a look at what is happening on the US markets before the opening bell on Wednesday. Below you can find the top gainers and losers in today's pre-market session.

Gainers

TickerChangeComment
PRTA59.39%PROTHENA CORP PLC's (NASDAQ:PRTA) shares rose 59.39% to $49.3. In the last 6 months the share price dropped with 20.81%.
BIIB53.95%BIOGEN INC's (NASDAQ:BIIB) stock price is advancing with 53.95% to a price of $304.5. The stock is trading 30.34% lower than a year ago.
LGVN27.79%LONGEVERON INC's (NASDAQ:LGVN) shares rose 27.79% to $5.15. In the last month the stock lost 24.11%.
BNTC18.92%BENITEC BIOPHARMA INC's (NASDAQ:BNTC) shares rose 18.92% to $0.38 during Wednesday's pre-market session. In the last month the stock lost 55.44%.
NNOX16.42%NANO-X IMAGING LTD's (NASDAQ:NNOX) shares rose 16.42% to $11.84. The stock is trading 23.36% lower than a month ago.
EFOI15.05%ENERGY FOCUS INC (NASDAQ:EFOI) rose 15.05% to $0.61 during Wednesday's pre-market session. The stock is trading 29.77% lower than a month ago.
BIVI14.4%BIOVIE INC's (NASDAQ:BIVI) shares rose 14.4% to $2.7 during Wednesday's pre-market session. In the last month the stock lost 26.48%.
TENX14.34%TENAX THERAPEUTICS INC (NASDAQ:TENX) rose 14.34% to $0.19 during Wednesday's pre-market session. The stock is trading 32.08% lower than a month ago.
IGC14.0%INDIA GLOBALIZATION CAPITAL's (NYSEARCA:IGC) shares rose 14.0% to $0.48. In the last month the share price dropped with 23.84%.
ELYS13.94%ELYS GAME TECHNOLOGY CORP's (NASDAQ:ELYS) shares rose 13.94% to $0.53 during Wednesday's pre-market session. In the last 3 months the stock lost 30.16%.

For the full premarket gainers list go to our premarket gainers screener.

Pre-market losers

TickerChangeComment
MNMD-38.07%MIND MEDICINE MINDMED INC's (NASDAQ:MNMD) shares fell 38.07% to $3.79 during Wednesday's pre-market session. In the last month the share price dropped with 49.04%.
PHAS-36.84%PHASEBIO PHARMACEUTICALS INC's (NASDAQ:PHAS) shares fell 36.84% to $0.48 during Wednesday's pre-market session. In the last month the stock lost 32.74%.
IBIO-33.58%IBIO INC's (NYSEARCA:IBIO) shares fell 33.58% to $0.21 during Wednesday's pre-market session. In the last 3 months the share price increased with 21.54%.
LTRYW-28.79%LOTTERY.COM -CW21's (NASDAQ:LTRYW) stock price is declining with 28.79% to a price of $0.01. In the last month the share price dropped with 37.93%.
NA-27.67%NANO LABS LTD-ADR's (NASDAQ:NA) shares fell 27.67% to $2.3. NASDAQ:NA already had a hard day yesterday: closing -15.83% lower during the regular session. Yesterday the company had a press release: Nano Labs Ltd Announces Pricing of Public Offering of American Depositary Shares.
ATXI-18.18%AVENUE THERAPEUTICS INC's (NASDAQ:ATXI) shares fell 18.18% to $5.94 during Wednesday's pre-market session. After yesterdays gain of 106.0%, it goes down with 18.18% in today's pre-market session.
GMDA-17.86%GAMIDA CELL LTD's (NASDAQ:GMDA) shares fell 17.86% to $1.61 during Wednesday's pre-market session. A press release (Gamida Cell Announces Entry into Commitment Letter with Highbridge for $25 Million Financing) was released yesterday.
PBTS-11.5%POWERBRIDGE TECHNOLOGIES CO's (NASDAQ:PBTS) shares fell 11.5% to $0.53. After running up 19.31% in yesterday's session, NASDAQ:PBTS is pulling back pre-market.
CGNT-11.36%COGNYTE SOFTWARE LTD's (NASDAQ:CGNT) stock price is declining with 11.36% to a price of $3.9. The company's earnings where released Yesterday. Earlier today the company had a press release: Cognyte Announces Second Quarter Results.
FHS-10.96%FIRST HIGH-SCHOOL EDUCAT-ADR's (NYSE:FHS) shares fell 10.96% to $0.65. In the last 6 months the stock lost 51.97%.

For the full premarket loser list go to our premarket losers screener.

Back

BENITEC BIOPHARMA INC

NASDAQ:BNTC (4/17/2024, 7:00:01 PM)

Premarket: 5.78 +0.98 (+20.42%)

4.8

+0.02 (+0.42%)

BNTC News

News Image15 minutes ago - Benitec Biopharma Inc.Benitec Biopharma Reports Positive Interim Clinical Trial Data for First OPMD Subject Treated with BB-301 in Phase 1b/2a Study

-First efficacy signals demonstrated for a gene therapy under development for Oculopharyngeal Muscular Dystrophy (OPMD) which affects ~15,000 patients...

News Imagean hour ago - Benitec Biopharma Inc.Benitec Biopharma Announces Oversubscribed Private Placement Financing of $40.0 Million

HAYWARD, Calif., April 18, 2024 (GLOBE NEWSWIRE) -- Benitec Biopharma Inc. (NASDAQ: BNTC) (“Benitec” or the “Company”), a clinical-stage, gene...

News Image2 months ago - Seeking AlphaBenitec Biopharma files for $125M mixed securities shelf (NASDAQ:BNTC)

Learn about the prospectus filed by Benitec Biopharma for the offer and sale of mixed securities, up to $125,000,000.

News Image2 months ago - Benitec Biopharma Inc.Benitec Biopharma Releases Second Quarter 2024 Financial Results and Provides Operational Update

-First Subject Dosed with BB-301 in Phase 1b/2a Clinical Treatment Study (NCT06185673) in November 2023- -Data Safety Monitoring Board Review for First...

News Image5 months ago - Benitec Biopharma Inc.Benitec Biopharma to Participate in a Fireside Chat at the 35th Annual Piper Sandler Healthcare Conference

HAYWARD, Calif., Nov. 17, 2023 (GLOBE NEWSWIRE) -- Benitec Biopharma Inc. (NASDAQ: BNTC) (“Benitec” or “Company”), a clinical-stage, gene...

News Image5 months ago - Benitec Biopharma Inc.Benitec Biopharma Releases First Quarter 2024 Financial Results and Provides Operational Update

Benitec Biopharma, a genetic medicines company, releases updates on OPMD program and other corporate and financial updates....

News Image7 months ago - Benitec Biopharma Inc.Benitec Biopharma Releases Full Year 2023 Financial Results and Provides Operational Update

Received FDA Clearance of the Investigational New Drug (IND) application for BB-301 for the Treatment of Oculopharyngeal Muscular Dystrophy (OPMD)-Related...

News Image8 months ago - Benitec Biopharma Inc.Benitec Biopharma Inc. Announces Closing of $30 Million Underwritten Public Offering
News Image8 months ago - Benitec Biopharma Inc.Benitec Biopharma Inc. Announces Closing of $30 Million Underwritten Public Offering

HAYWARD, Calif., Aug. 11, 2023 (GLOBE NEWSWIRE) -- Benitec Biopharma Inc. (Nasdaq: BNTC) (“Benitec” or the “Company”), a clinical-stage, gene...

News Image8 months ago - Seeking AlphaBenitec Biopharma prices $30M equity offering (NASDAQ:BNTC)

Benitec Biopharma (BNTC) priced its underwritten public offering of ~15.54M shares and warrants to purchase up to ~15.54M shares.The offering is expected to close on August...

News Image8 months ago - Benitec Biopharma Inc.Benitec Biopharma Inc. Announces Pricing of $30 Million Underwritten Public Offering

HAYWARD, Calif., Aug. 08, 2023 (GLOBE NEWSWIRE) -- Benitec Biopharma Inc. (Nasdaq: BNTC) (“Benitec” or the “Company”), a clinical-stage, gene...

News Image9 months ago - The Motley FoolWhy Novavax Stock Zoomed 13% Higher on Monday

A renewed fight against COVID-19 might be coming.

BNTC Links
Follow us for more